5-lipoxygenase-activating protein (FLAP) inhibitors
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Oct 1, 2013
Grant Date -
Apr 25, 2013
app pub date -
Oct 30, 2012
filing date -
Oct 1, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A method for treating a human comprises administering a therapeutically effective amount of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid or a pharmaceutically acceptable salt or a pharmaceutically acceptable N-oxide thereof, to the human in need.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully